<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33877110</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0016-3813</ISSN><JournalIssue CitedMedium="Internet"><Volume>156</Volume><Issue>6</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Gaceta medica de Mexico</Title><ISOAbbreviation>Gac Med Mex</ISOAbbreviation></Journal><ArticleTitle>Importance of the list of essential medicines in medical prescription.</ArticleTitle><Pagination><StartPage>598</StartPage><EndPage>599</EndPage><MedlinePgn>598-599</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/GMM.M21000496</ELocationID><Abstract><AbstractText>The implementation of an essential medicines list in health institutions allows acquiring and administering a long list of drugs that offers treatment alternatives to physicians, as well as a collegiate academic description of indications, doses, side effects, interactions and cost-benefit analyses, thus facilitating medical prescription and administration of health products. The Committee of Ethics and Transparency in the Physician-Industry Relationship issues several recommendations for optimizing the benefits generated by essential medicines lists. La implementaci&#xf3;n en instituciones de salud de un cuadro b&#xe1;sico permite adquirir y administrar una larga lista de medicamentos que presenta a los m&#xe9;dicos las alternativas de tratamiento, as&#xed; como la descripci&#xf3;n acad&#xe9;mica colegiada de indicaciones, dosis, efectos secundarios, interacciones y an&#xe1;lisis de costo-beneficio, con lo que se facilita la prescripci&#xf3;n m&#xe9;dica y la administraci&#xf3;n de insumos para la salud. El Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria emite diversas recomendaciones para la optimizaci&#xf3;n de los beneficios generados por los cuadros b&#xe1;sico de medicamentos.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2020 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jasso</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lifshitz</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrieta</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgos</LastName><ForeName>Rub&#xe9;n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campillo</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Celis</LastName><ForeName>Miguel &#xc1;</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llata</LastName><ForeName>Manuel de la</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halabe</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islas</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Mucio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plancarte</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-S&#xe1;nchez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Arg&#xfc;elles</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soda</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotelo</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ver&#xe1;stegui</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Academia Nacional de Medicina, Comit&#xe9; de &#xc9;tica y Transparencia en la Relaci&#xf3;n M&#xe9;dico-Industria (CETREMI), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Importancia del cuadro b&#xe1;sico de medicamentos en la prescripci&#xf3;n m&#xe9;dica.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Gac Med Mex</MedlineTA><NlmUniqueID>0010333</NlmUniqueID><ISSNLinking>0016-3813</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018954">Drugs, Essential</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="Y">Drug Prescriptions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018954" MajorTopicYN="N">Drugs, Essential</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017041" MajorTopicYN="Y">Ethics Committees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017408" MajorTopicYN="Y">Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cost-benefit</Keyword><Keyword MajorTopicYN="N">Costo de medicamentos</Keyword><Keyword MajorTopicYN="N">Costo-beneficio</Keyword><Keyword MajorTopicYN="N">Cuadro b&#xe1;sico</Keyword><Keyword MajorTopicYN="N">Essential medicines list</Keyword><Keyword MajorTopicYN="N">Medication cost</Keyword><Keyword MajorTopicYN="N">New drugs</Keyword><Keyword MajorTopicYN="N">Nuevos f&#xe1;rmacos</Keyword><Keyword MajorTopicYN="N">Prescripci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Prescription</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>12</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33877110</ArticleId><ArticleId IdType="doi">10.24875/GMM.M21000496</ArticleId><ArticleId IdType="pii">j156/6/598</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>